...
首页> 外文期刊>International journal of oncology >DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells
【24h】

DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells

机译:DNA甲基转移酶3样独立于癌细胞中的DNMT1和DNMT3B影响胸腺嘧啶DNA糖基化酶的启动子甲基化

获取原文
   

获取外文期刊封面封底 >>

       

摘要

DNA methyltransferase (DNMT) 1 and 3 are primarily responsible for abnormal methylation in cancer. Unlike these DNMTs, DNA methyltransferase 3-like (DNMT3L) harbors no conserved catalytic domain, and has been shown to function as a regulatory cofactor for DNA methylation. However, it is unclear whether DNMT3L directly regulates DNA methylation in cancer cells. To address this, we investigated the methylation targets of DNMT3L by conducting methylation microarray trials after the siRNA-induced knockdown. We determined that methylation of 242 out of 1,505 CpG sites was significantly altered by DNMT3L knockdown. Among these 242 CpG sites, 204, 12, and 11 CpG sites were identified as common targets of DNMT 1/3B/3L, 1/3L, and 3B/3L, respectively; this indicates that DNMT3L participates in DNA methylation via cooperation with other DNMTs. However, we also determined that the methylation of 15 CpG sites was significantly altered by DNMT3L knockdown only. As a validation, we confirmed that thymine DNA glycosylase (TDG), an enzyme involved in the base excision repair of mismatched-DNA, was up-regulated in DNMT3L knockdown cells, but neither in DNMT1 nor 3B knockdown cells. Methylation-specific PCR (MSP) also showed that promoter methylation of TDG was decreased in DNMT3L knockdown cells. Interestingly, 5-aza-2'-deoxycitidine (5-aza-dC) re-expressed DNMT3L, leading to down-regulation of TDG. This study is the first to show that DNMT3L exerts a major effect on the transcriptional regulation of a specific target gene, such as TDG, despite the absence of enzymatic activity.
机译:DNA甲基转移酶(DNMT)1和3主要负责癌症中的异常甲基化。与这些DNMT不同,DNA甲基转移酶3样(DNMT3L)没有保守的催化结构域,并且已显示出可作为DNA甲基化的调节辅助因子。但是,尚不清楚DNMT3L是否直接调节癌细胞中的DNA甲基化。为了解决这个问题,我们通过在siRNA诱导的敲除后进行甲基化微阵列试验研究了DNMT3L的甲基化靶标。我们确定DNMT3L敲低显着改变了1,505个CpG位点中242个的甲基化。在这242个CpG位点中,分别将204、12和11个CpG位点确定为DNMT 1 / 3B / 3L,1 / 3L和3B / 3L的共同目标。这表明DNMT3L通过与其他DNMT的合作参与DNA甲基化。但是,我们还确定了15个CpG位点的甲基化仅被DNMT3L敲除显着改变。作为验证,我们证实了胸腺嘧啶DNA糖基化酶(TDG),一种参与错配DNA的碱基切除修复的酶,在DNMT3L敲低细胞中被上调,但在DNMT1或3B敲低细胞中均未上调。甲基化特异性PCR(MSP)也显示,DNMT3L敲低细胞中TDG的启动子甲基化降低。有趣的是,5-氮杂-2'-脱氧胞苷(5-氮杂-dC)重新表达了DNMT3L,导致TDG的下调。这项研究是第一个表明DNMT3L对特定靶基因(如TDG)的转录调节起着主要作用,尽管没有酶促活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号